The World Health Organization issued a warning against four cough and cold syrups manufactured by Maiden Pharmaceuticals in India after 66 young children died in the Gambia. According to reports, cough and cold syrups contain substances including diethylene glycol and ethylene glycol, both of which can be hazardous to humans.
A brief about WHO issues warning against four cough syrups produced by Maiden Pharmaceuticals in India
According to reports, the Gambian government stated that it has been looking into the deaths of young children under the age of five due to an increase in acute renal injury cases that began to surface in July.
The international agency declared that it is working with the business and Indian regulatory authorities to do additional research.
According to news reports, the four syrups that have been discovered are Magrip N Cold Syrup, Kofexmalin Baby Cough Syrup, Promethazine Oral Solution, and Kofexmalin Baby Cough Syrup.
The WHO issued a medical product alert stating that “laboratory examination of samples (in the syrup) of each of the four products indicates that they contain excessive quantities of diethylene glycol and ethylene glycol as contaminants.”
The World Health Organization’s director general, Tedros Adhanom Ghebreyesus, stated in a tweet that “WHO has today issued a medical product warning for four tainted medicines detected in The Gambia that have a potential relation to acute renal injuries and 66 child deaths.”
He continued by saying that the loss of these young lives was unbearably tragic for their families. The four medications are syrups for colds and coughs made by the Indian company Maiden Pharmaceuticals Limited.
While the contaminated products have only been found in the Gambia thus far, Ghebreyesus reportedly claimed at a news conference that they “may have been distributed to other nations.”
The global health organization will request that all nations find these products and remove them from circulation in order to protect people from additional harm, he added.
